Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.

Journal of cardiovascular translational research

Volumn 1, Issue 1, 2008, Pages 25-36

  Wheeler, Matthew T ^a   Ho, Michael ^b   Knowles, Joshua W ^b   Pavlovic, Aleks ^b   Ashley, Euan A ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CARDIOVASCULAR AGENT;

BIOTRANSFORMATION; DRUG EFFECT; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HEART FAILURE; HUMAN; PATIENT SELECTION; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTION AND FORECASTING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT OUTCOME;

BIOTRANSFORMATION; CARDIOVASCULAR AGENTS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; HEART FAILURE; HUMANS; INDIVIDUALIZED MEDICINE; PATIENT SELECTION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RECEPTORS, ADRENERGIC, BETA; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 77957921901     PISSN: None     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-007-9007-8     Document Type: Review

References (87)